Document is current
Any future updates will be listed below
-
Authors
Mengel, David https://orcid.org/0000-0002-4133-7182
Traschütz, Andreas
Reich, Selina
Leyva-Gutiérrez, Alejandra
Bender, Friedemann
Hauser, Stefan
Haack, Tobias B.
Synofzik, Matthis
-
Funding
Funding for this research was provided by:
DFG (441409627)
Horizon 2020 (779257)
European Reference Network for Rare Neurological Diseases (739510)
European Reference Network for Rare Neurological Diseases (739510)
Medical faculty of Tübingen University
Eberhard Karls Universität Tübingen
- License Information
-
More Information
Article History
Received: 6 December 2020
Revised: 3 March 2021
Accepted: 15 March 2021
First Online: 3 April 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: The study was also approved by the Ethical Review Board Tübingen, as part of a general approval to study the clinical and genetic characteristics of degenerative ataxia patients (Az 598/2011BO1).
: Written informed consent for genetic analyses and functional experiments of the blood from the patient, his relatives, and both control patients were obtained.
